SAR443579
An Open-label, First-in-human, Dose-escalation/Expansion Study of SAR443579 Administered as Single Agent by Intravenous Infusion in Adult and Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Filters
Save & Share
Clear Filters
Location
Explore options near your center - or near your patient's home.
MDS Centers of Excellence
Diagnosis
Purpose of Trial
Filter and find trials based on their purpose.
Risk Level
Enter this patient's risk level (IPSS-R / IPSS-M).
Near Add Your Location
Sorting 10 by
Center of Excellence
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
Weill Cornell
New York, NY
- Accepting patients
Center of Excellence
- Accepting patients
Center of Excellence
Montefiore Medical Center
Bronx, NY
- Accepting patients
- Accepting patients
Beth Israel Deaconess Medical Center
Boston, MA
- Accepting patients
Center of Excellence
Ohio State University Comprehensive Cancer Center
James Cancer Hospital and Solove Research Institute
Columbus, OH
- Accepting patients
Children's Hospital of Philadelphia
Philadelphia, PA
- Accepting patients
Seattle Children's Hospital
Seattle, WA
- Accepting patients
514 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.